Page last updated: 2024-08-21

pyrazines and Niemann-Pick Disease, Type C

pyrazines has been researched along with Niemann-Pick Disease, Type C in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bachs, O; Coll, MJ; Gascón, P; Girós, M; Guerrero, M; Macías-Vidal, J; Serratosa, J	1

Other Studies

1 other study(ies) available for pyrazines and Niemann-Pick Disease, Type C

Article	Year
The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann-Pick type C patients carrying missense mutations. The FEBS journal, 2014, Volume: 281, Issue:19 Topics: Boronic Acids; Bortezomib; Carrier Proteins; Cells, Cultured; Cholesterol; Endosomes; Fibroblasts; Humans; Intracellular Signaling Peptides and Proteins; Leupeptins; Membrane Glycoproteins; Mutation, Missense; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Stability; Protein Transport; Proteolysis; Pyrazines	2014

Article

Year

The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann-Pick type C patients carrying missense mutations.

The FEBS journal, 2014, Volume: 281, Issue:19

Topics: Boronic Acids; Bortezomib; Carrier Proteins; Cells, Cultured; Cholesterol; Endosomes; Fibroblasts; Humans; Intracellular Signaling Peptides and Proteins; Leupeptins; Membrane Glycoproteins; Mutation, Missense; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Stability; Protein Transport; Proteolysis; Pyrazines

2014